Your search returned 4 results.

Results
	1.	Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply. [electronic resource] by Mücke, M M Mücke, V T Vermehren, J Producer: 20171220 In: Alimentary pharmacology & therapeutics vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply. [electronic resource] by Mücke, M M Mücke, V T Vermehren, J Producer: 20171220 In: Alimentary pharmacology & therapeutics vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Letter: adoption of uniform nomenclature is crucial for estimating the true risk of HBV reactivation in patients treated with direct-acting antivirals for hepatitis C. [electronic resource] by Mücke, M M Mücke, V T Vermehren, J Producer: 20190729 In: Alimentary pharmacology & therapeutics vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort. [electronic resource] by Mücke, V T Mücke, M M Peiffer, K-H Weiler, N Welzel, T M Sarrazin, C Zeuzem, S Berger, A Vermehren, J Producer: 20171207 In: Alimentary pharmacology & therapeutics vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)